• WisBusiness

Tuesday, May 04, 2010

 1:42 PM 

Exact Sciences moving closer to clinical trials

CHICAGO -- Madison-based Exact Science is nearing a pre-clinical trial of its non-invasive screening technology for the detection of colorectal cancer, CEO Kevin Conroy said Tuesday during the 2010 BIO International Convention.

With a recent stock offering that raised more than $18 million from 25 public company investors, Exact Sciences is poised to move ahead with tests involving 3,000 samples, perhaps as early as this summer. "This will be a really major step for us," said Conroy, who noted that full clinical trials could begin in mid-2011.

Exact Sciences moved from Boston, Mass., to Madison in 2009 to develop its stool-based DNA technology. Conroy is the former CEO of Third Waves Technologies in Madison, which was acquired by Hologic.

Labels:


BIO BLOG SPONSOR

wisbusiness.com Social News

Follow Us

Site Sponsors

ARCHIVE

· 04/01/2006 - 05/01/2006
· 05/01/2007 - 06/01/2007
· 06/01/2008 - 07/01/2008
· 05/01/2009 - 06/01/2009
· 10/01/2009 - 11/01/2009
· 01/01/2010 - 02/01/2010
· 02/01/2010 - 03/01/2010
· 03/01/2010 - 04/01/2010
· 04/01/2010 - 05/01/2010
· 05/01/2010 - 06/01/2010
· 06/01/2011 - 07/01/2011
· 07/01/2011 - 08/01/2011
· 06/01/2012 - 07/01/2012
Copyright ©2012 WisBusiness.com All rights reserved. | WisOpinion.com | WisPolitics.com  |  Website development by wisnet.com LLC  | Website design by Makin’ Hey Communications